End-of-day quote
Taipei Exchange
18:00:00 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
23.3
TWD
|
0.00%
|
|
+1.30%
|
-12.41%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
697
|
720.8
|
3,606
|
1,615
|
1,221
|
1,152
|
Enterprise Value (EV)
1 |
511.2
|
498.9
|
2,781
|
1,306
|
1,010
|
962.6
|
P/E ratio
|
49
x
|
25.2
x
|
4.93
x
|
14.5
x
|
42.7
x
|
-23.5
x
|
Yield
|
3.11%
|
12%
|
12%
|
4.02%
|
1.77%
|
3.76%
|
Capitalization / Revenue
|
0.85
x
|
0.92
x
|
1.38
x
|
1.64
x
|
2.16
x
|
2.75
x
|
EV / Revenue
|
0.63
x
|
0.64
x
|
1.06
x
|
1.33
x
|
1.79
x
|
2.3
x
|
EV / EBITDA
|
17.5
x
|
9.86
x
|
2.86
x
|
7.44
x
|
80.8
x
|
-21.3
x
|
EV / FCF
|
101
x
|
7.77
x
|
4.74
x
|
-7.49
x
|
-16
x
|
27.6
x
|
FCF Yield
|
0.99%
|
12.9%
|
21.1%
|
-13.4%
|
-6.23%
|
3.62%
|
Price to Book
|
1.05
x
|
1.09
x
|
2.68
x
|
1.51
x
|
1.2
x
|
1.24
x
|
Nbr of stocks (in thousands)
|
43,290
|
43,290
|
43,290
|
43,290
|
43,290
|
43,290
|
Reference price
2 |
16.10
|
16.65
|
83.30
|
37.30
|
28.20
|
26.60
|
Announcement Date
|
19-03-29
|
20-03-25
|
21-03-31
|
22-03-29
|
23-03-25
|
24-03-15
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
815.2
|
784.9
|
2,617
|
985
|
564.6
|
418.5
|
EBITDA
1 |
29.23
|
50.59
|
971.6
|
175.7
|
12.51
|
-45.13
|
EBIT
1 |
10.48
|
30.26
|
951.2
|
149.5
|
-15.18
|
-76.17
|
Operating Margin
|
1.29%
|
3.85%
|
36.35%
|
15.17%
|
-2.69%
|
-18.2%
|
Earnings before Tax (EBT)
1 |
19.8
|
35.83
|
919
|
140.5
|
33.87
|
-63.25
|
Net income
1 |
14.23
|
28.77
|
736.4
|
112.5
|
28.66
|
-48.77
|
Net margin
|
1.75%
|
3.66%
|
28.14%
|
11.42%
|
5.08%
|
-11.65%
|
EPS
2 |
0.3287
|
0.6600
|
16.88
|
2.580
|
0.6600
|
-1.130
|
Free Cash Flow
1 |
5.076
|
64.19
|
586.6
|
-174.5
|
-62.96
|
34.86
|
FCF margin
|
0.62%
|
8.18%
|
22.42%
|
-17.71%
|
-11.15%
|
8.33%
|
FCF Conversion (EBITDA)
|
17.36%
|
126.88%
|
60.38%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
35.67%
|
223.14%
|
79.67%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5000
|
2.000
|
10.00
|
1.500
|
0.5000
|
1.000
|
Announcement Date
|
19-03-29
|
20-03-25
|
21-03-31
|
22-03-29
|
23-03-25
|
24-03-15
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
186
|
222
|
825
|
308
|
210
|
189
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
5.08
|
64.2
|
587
|
-174
|
-63
|
34.9
|
ROE (net income / shareholders' equity)
|
2.13%
|
4.34%
|
73.4%
|
9.32%
|
2.74%
|
-5.01%
|
ROA (Net income/ Total Assets)
|
0.82%
|
2.39%
|
43.9%
|
5.9%
|
-0.8%
|
-4.54%
|
Assets
1 |
1,739
|
1,201
|
1,677
|
1,905
|
-3,561
|
1,074
|
Book Value Per Share
2 |
15.40
|
15.20
|
31.10
|
24.70
|
23.60
|
21.40
|
Cash Flow per Share
2 |
4.290
|
5.120
|
18.60
|
6.820
|
4.560
|
4.060
|
Capex
1 |
12.1
|
10.9
|
29.1
|
17.1
|
9.65
|
11.4
|
Capex / Sales
|
1.48%
|
1.39%
|
1.11%
|
1.73%
|
1.71%
|
2.72%
|
Announcement Date
|
19-03-29
|
20-03-25
|
21-03-31
|
22-03-29
|
23-03-25
|
24-03-15
|
|
1st Jan change
|
Capi.
|
---|
| -12.41% | 31.09M | | +73.37% | 12.38B | | -17.09% | 7.99B | | +16.88% | 7.21B | | +3.57% | 5.79B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -17.74% | 4.17B | | -35.26% | 2.44B | | +3.09% | 2.03B |
Medical Equipment
|